RA CAPITAL MANAGEMENT

RA Capital Management is a Boston-based venture capital and investment firm focused primarily on healthcare and life sciences. Founded in 2002, the firm invests across multiple stages, from seed funding to IPO, in companies developing drugs, medical devices, diagnostics, and research tools. RA Capital is known for its deep scientific and market expertise, facilitated by its internal research division, TechAtlas, which provides insights into competitive landscapes and helps guide investment decisions. The firm supports startups through its RAVen incubator, offering resources beyond capital, including strategic guidance, technology transfer, and executive recruitment. RA Capital has a strong commitment to innovation in human health, working closely with academics, entrepreneurs, and executives to bring groundbreaking therapies and technologies to market. Some notable portfolio companies include Moderna, Natera, and Peloton Therapeutics. RA Capital’s approach emphasizes evidence-based investing, focusing on creating value through informed decision-making and long-term growth.